Provided by Tiger Trade Technology Pte. Ltd.

Carpenter Technology

406.37
+6.901.73%
Volume:340.87K
Turnover:137.19M
Market Cap:20.24B
PE:47.20
High:407.35
Open:403.20
Low:394.19
Close:399.47
52wk High:412.31
52wk Low:138.61
Shares:49.82M
Float Shares:48.50M
Volume Ratio:0.75
T/O Rate:0.70%
Dividend:0.80
Dividend Rate:0.20%
EPS(TTM):8.61
EPS(LYR):7.42
ROE:23.49%
ROA:10.75%
PB:10.20
PE(LYR):54.77

Loading ...

PeproMene Bio's PMB-CT01 BAFFR-CAR T Data Selected for Two Oral Presentations at 67th ASH 2025 Annual Meeting

prnewswire
·
Nov 20, 2025

Antengene Hosts 2025 R&D Day Showcasing Encouraging Clinical Data and Solid Progress with Investigational Programs

prnewswire
·
Nov 20, 2025

Carpenter Technology Corporation Announces Pricing Of $700.0 Million Private Offering Of 5.625% Senior Notes Due 2034

Reuters
·
Nov 20, 2025

Genmab Announces EPKINLY® (epcoritamab-bysp) in Combination with Rituximab and Lenalidomide Approved by the U.S. Food and Drug Administration for the Treatment of Relapsed or Refractory Follicular Lymphoma

GlobeNewswire
·
Nov 19, 2025

Should Carpenter Technology’s (CRS) $700 Million Debt Refinance Reshape Its Financial Flexibility?

Simply Wall St.
·
Nov 18, 2025

U.S. RESEARCH ROUNDUP-Disney, Enanta Pharmaceuticals, Phillips 66

Reuters
·
Nov 14, 2025

Carpenter Technology Corp : TD Cowen Raises Target Price to $380 From $340

THOMSON REUTERS
·
Nov 14, 2025

Strong Market Position and Growth Potential Drive Buy Rating for Carpenter Technology

TIPRANKS
·
Nov 14, 2025

Carpenter Technology (CRS): Assessing Valuation After $700 Million Debt Offering and Capital Structure Move

Simply Wall St.
·
Nov 14, 2025

Cartesian Therapeutics Announces Strong Efficacy Signal in Phase 2 Trial of Descartes-08 in Patients with SLE and Expansion of Clinical Development into Myositis

GlobeNewswire
·
Nov 14, 2025

SeaStar Medical Reports Third Quarter 2025 Financial Results and Provides Business Updates

GlobeNewswire
·
Nov 14, 2025

Fate Therapeutics Reports Third Quarter 2025 Financial Results and Business Updates

GlobeNewswire
·
Nov 13, 2025

Regeneron Highlights Progress at American Society of Hematology (ASH), with Updated Data in Multiple Myeloma, Lymphoma and Paroxysmal Nocturnal Hemoglobinuria Programs

GlobeNewswire
·
Nov 13, 2025

KeyBanc Upgrades Carpenter Technology to Overweight From Sector Weight, Sets $380 Price Target

MT Newswires Live
·
Nov 13, 2025

Carpenter Tech Raised to Overweight From Sector Weight by Keybanc

Dow Jones
·
Nov 13, 2025

Carpenter Technology Corp : Keybanc Raises to Overweight From Sector Weight

THOMSON REUTERS
·
Nov 13, 2025

Can Carpenter Technology’s (CRS) Debt Refinance Reveal a New Phase of Financial Discipline?

Simply Wall St.
·
Nov 11, 2025

Carpenter Technology Launches $700 Million Senior Notes Offering

Reuters
·
Nov 10, 2025

Carpenter Technology Corporation Announces Proposed $700.0 Million Private Offering of Senior Notes Due 2034

THOMSON REUTERS
·
Nov 10, 2025

Context Therapeutics Highlights CT-95 and CT-202 Programs at 2025 SITC Annual Meeting

GlobeNewswire
·
Nov 07, 2025